N-[4-(4-amino-1-cyclopentylpyrazolo[3,4-d]pyrimidin-3-yl)-2-fluorophenyl]-2,6-dichlorobenzenesulfonamide
C22H19Cl2FN6O2S — CID 59981413
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[4-(4-amino-1-cyclopentylpyrazolo[3,4-d]pyrimidin-3-yl)-2-fluorophenyl]-2,6-dichlorobenzenesulfonamide
N-[4-(4-amino-1-cyclopentylpyrazolo[3,4-d]pyrimidin-3-yl)-2-fluorophenyl]-2,6-dichlorobenzenesulfonamide (PubChem CID 59981413) has the molecular formula C22H19Cl2FN6O2S and a molecular weight of 521.41 g/mol. Its IUPAC name is N-[4-(4-amino-1-cyclopentylpyrazolo[3,4-d]pyrimidin-3-yl)-2-fluorophenyl]-2,6-dichlorobenzenesulfonamide.
Molecular Properties
| Compound Name | N-[4-(4-amino-1-cyclopentylpyrazolo[3,4-d]pyrimidin-3-yl)-2-fluorophenyl]-2,6-dichlorobenzenesulfonamide |
|---|---|
| PubChem CID | 59981413 |
| Molecular Formula | C22H19Cl2FN6O2S |
| Molecular Weight | 521.41 g/mol |
| Exact Mass | 520.07 |
| IUPAC Name | N-[4-(4-amino-1-cyclopentylpyrazolo[3,4-d]pyrimidin-3-yl)-2-fluorophenyl]-2,6-dichlorobenzenesulfonamide |
| SMILES | Nc1ncnc2c1c(-c1ccc(NS(=O)(=O)c3c(Cl)cccc3Cl)c(F)c1)nn2C1CCCC1 |
| InChI | InChI=1S/C22H19Cl2FN6O2S/c23-14-6-3-7-15(24)20(14)34(32,33)30-17-9-8-12(10-16(17)25)19-18-21(26)27-11-28-22(18)31(29-19)13-4-1-2-5-13/h3,6-11,13,30H,1-2,4-5H2,(H2,26,27,28) |
| InChIKey | WLNNESUOACOPMG-UHFFFAOYSA-N |
| XLogP | 5.44 |
| TPSA | 115.79 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 521.41 |
| LogP ≤ 5 | 5.44 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 59981413 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.